Govt approves 8 Medical Device companies under PLI scheme

The empowered committee also approved various applicants in the bulk drugs segment as well

181
Govt of India

The government has accorded approval to eight medical device companies under the production linked incentive (PLI) scheme to promote domestic manufacturing of medical devices, the Ministry of Chemicals and Fertilisers said.

The approvals were given during the ninth meeting of the empowered committee held on November 25 after considering all the applications as per the scheme guidelines, the ministry said in a statement.

“The setting up of these eight plants will lead to a total committed investment of Rs 260.4 crore by the companies and employment generation of about 2,599. The commercial production is projected to commence from April 1, 2023, onwards,” it added.

With this, the total applications approved under both rounds aggregated to 21 applicants with a committed investment of Rs 1,059.33 crore and employment generation of about 6,411, the statement noted.

The setting of these plants will make the country self-reliant to a large extent in the specified target segments in the medical devices sector, it added.

With the objective of boosting domestic manufacturing and attracting large investment in the medical device sector, the Department of Pharmaceuticals launched a PLI scheme to ensure a level playing field for the domestic manufacturers of medical devices with a total financial outlay of Rs 3,420 crore for the period 2020-21 to 2027-28.

In a separate statement, the ministry said that the empowered committee also approved various applicants in the bulk drugs segment as well.

The establishment of eight plants would lead to a total committed investment of about Rs 151.12 crore by the companies and employment generation of about 1,951, the statement noted.

The commercial production of these plants is projected to commence from April 1, 2023, onwards, it added.

“With this, the total applications approved under both rounds aggregate to 50 applicants with committed investment of Rs 4,498.38 crore and employment generation of about 10,743. Setting up of these plants will make the country self-reliant to a large extent in respect of these Bulk drugs,” the ministry said.

Currently, India is significantly dependent on the import of basic raw materials — bulk drugs that are used to produce medicines.

In some specific bulk drugs, the import dependence is 80 to 100 percent.

Licensing procedure for Medical devices

Latest Notifications: Medical Devices

Classifications of Medical Devices under the provisions of MDR 2017

FAQs on Medical Devices Rules, 2017   

FAQs – on Blood Pressure Monitoring Devices

Pharmexcil is seeking candidates for the role of Director

NABL accreditation for Drug Testing Laboratory in Chennai: TN

Dr Reddy’s launches drug to treat high Blood Pressure, Heart failure

IPC flags safety alert against NSAID Diclofenac

Narcotics Drugs: Team raids Zirakpur Pharmaceuticals firm

Sun Pharma gets CDSCO panel nod for FDC Brinzolamide, Timolol, Pot…

Procedure for registration of Medical Devices: CDSCO

Procedure to obtain license for Commercial Testing Laboratories

NPPA fixes retail price of 20 formulations: December 2021

Latest Notifications regarding Pharmaceuticals

For informative videos on Medical Devices, click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner